Price T Rowe Associates Inc Merck & Co., Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 24,725,061 shares of MRK stock, worth $2.5 Billion. This represents 0.37% of its overall portfolio holdings.

Number of Shares

24,725,061

Previous 29,639,517 16.58%

Holding current value

$2.5 Billion

Previous $3.91 Billion 21.73%

% of portfolio

0.37%

Previous 0.48%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $608 Million - $653 Million	-4,914,456 Reduced 16.58%	24,725,061 $3.06 Billion
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $50.7 Million - $59.1 Million	-447,700 Reduced 1.49%	29,639,517 $3.91 Billion
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $81.1 Million - $88.2 Million	809,052 Added 2.76%	30,087,217 $3.28 Billion
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $11.6 Million - $12.8 Million	-112,224 Reduced 0.38%	29,278,165 $3.01 Billion
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $48.7 Million - $53 Million	-448,026 Reduced 1.5%	29,390,389 $3.39 Billion
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $363 Million - $405 Million	3,524,385 Added 13.39%	29,838,415 $3.17 Billion
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $966 Million - $1.24 Billion	11,051,945 Added 72.41%	26,314,030 $2.92 Billion
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $149 Million - $168 Million	-1,764,865 Reduced 10.37%	15,262,085 $1.31 Billion
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $176 Million - $200 Million	2,111,477 Added 14.16%	17,026,950 $1.55 Billion
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $176 Million - $197 Million	-2,389,330 Reduced 13.81%	14,915,473 $1.22 Billion
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $86.5 Million - $108 Million	-1,197,067 Reduced 6.47%	17,304,803 $1.33 Billion
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $224 Million - $247 Million	3,128,468 Added 20.35%	18,501,870 $1.39 Billion
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $179 Million - $198 Million	-2,542,520 Reduced 14.19%	15,373,402 $1.2 Billion
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $71.6 Million - $84.4 Million	-1,040,270 Reduced 5.49%	17,915,922 $1.38 Billion
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $1.36 Billion - $1.51 Billion	18,956,192 New	18,956,192 $1.55 Billion

Others Institutions Holding MRK

# of Institutions

3,802

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Merck & Co., Inc. Transaction History